Last reviewed · How we verify
NCT05410990
Eosinophil Indices in Patients With Acute Heart Failure
trial testing eosinophil and other hematological parameters in Acute Heart Failure in 395 participants. Completed in 5 April 2022.
30 December 2021
Quick facts
| Lead sponsor | Giresun University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 395 |
| Start date | 2 January 2017 |
| Primary completion | 30 December 2021 |
| Estimated completion | 5 April 2022 |
Drugs / interventions tested
- eosinophil and other hematological parameters
Conditions studied
- Acute Heart Failure — all drugs for Acute Heart Failure →
- Reduced Systolic Function — all drugs for Reduced Systolic Function →
Sponsor
Giresun University
Who can join
Adults 18 to 90, any sex, with Acute Heart Failure or Reduced Systolic Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All consecutive patients admitted to the intensive care unit (ICU) with ADHF between January 2017 and December 2021 were enrolled in this retrospective study. All-cause mortality and MACE were assessed with respect to relationships with eosinophil indices, including neutrophil-to-eosinophil ratio (NER), leukocyte-to-eosinophil ratio (LER), eosinophil-to-lymphocyte ratio (ELR), and eosinophil-to-monocyte ratio (EMR).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05410990
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Heart Failure
Currently open trials in the same condition.
- NCT06587854 — a PRagmatic Observational Study of Congestion proFILes in patiEnts With Acute Heart Failure · recruiting
- NCT07008365 — The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure · Phase 3 · recruiting
- NCT06465498 — Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography · NA · recruiting
- NCT06597331 — Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital · recruiting
- NCT06166654 — Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload · Phase 4 · recruiting
Other Giresun University trials
Trials by the same sponsor.
- NCT07520916 — The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatec · NA · recruiting
- NCT07401914 — Ketodex Versus Ketofol in Adolescent Gastrointestinal Endoscopy · not yet recruiting
- NCT07401927 — Preemptive Analgesia in Laparoscopic Hysterectomy · not yet recruiting
- NCT07283172 — The Effect of Virtual Reality · NA · not yet recruiting
- NCT07427147 — CULTURAL SENSITIVITY TRAINING · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05410990 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Giresun University
- Last refreshed: 8 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410990.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing